Inhaled corticosteroids administration/withdrawal as a therapeutic continuum for patients with chronic obstructive pulmonary disease in real clinical practice
| العنوان: | Inhaled corticosteroids administration/withdrawal as a therapeutic continuum for patients with chronic obstructive pulmonary disease in real clinical practice |
|---|---|
| المؤلفون: | S. N. Avdeev, Z. R. Aisanov, V. V. Arkhipov, A. S. Belevskiy, A. A. Vizel, I. V. Demko, A. V. Emelyanov, A. A. Zaycev, G. L. Ignatova, N. P. Kniajeskaia, L. M. Kudelya, I. V. Leshchenko, S. I. Ovcharenko, A. I. Sinopalnikov, I. N. Trofimenko, V. D. Fedotov, R. F. Khamitov |
| المصدر: | PULMONOLOGIYA. 33:109-118 |
| بيانات النشر: | Scientific and Practical Reviewed Journal Pulmonology, 2023. |
| سنة النشر: | 2023 |
| مصطلحات موضوعية: | Pulmonary and Respiratory Medicine |
| الوصف: | Chronic obstructive pulmonary disease (COPD) is a progressing disease. Each exacerbation impairs the patient’s prognosis and increases burden for the healthcare system. The most common maintenance treatment options for COPD include long-acting bronchodilators – β2-agonists (LABA) and long-acting antimuscarinic agents (LAMA), and inhaled glucocorticosteroids (ICS), in fixed/opened double and triple combinations. Triple therapy in subjects with exacerbation history is the most effective way to prevent negative outcomes of the disease. It can reduce the frequency of exacerbations, slow down the disease progression, improve quality of life, and reduce mortality in the long run. On the other hand, the response to triple therapy may change over the time depending on airways inflammation level, infection activity, and exacerbation frequency. Current COPD guidelines propose different indications for therapy escalation and de-escalation (ICS addition/withdrawal) for more personalized and safe treatment. At the same time, many practical issues of this process are still unclear, e.g. how often treatment regimens should be reviewed and what escalation/de-escalation criteria should be prioritized. The authors strongly believe that COPD therapy should adapt a holistic treatment approach (continuum) with quick responses to any changes in the patient’s condition.The aim of our work was to create an algorithm for ICS administration/ withdrawal for COPD patients on long-acting dual bronchodilators maintenance therapy and to establish a therapeutic continuum that takes into account exacerbation history, symptoms severity, blood eosinophilia level, and concomitant asthma.Conclusion. This instrument can be a useful and convenient tool for long-term patient management when access to specialized medical care might be restricted. It takes into account the main current recommendations for COPD management and is easy to apply in real clinical practice. |
| تدمد: | 2541-9617 0869-0189 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::d5704e94708cbb7c319d471536942f02 https://doi.org/10.18093/0869-0189-202333-1-109-118 |
| حقوق: | CLOSED |
| رقم الأكسشن: | edsair.doi...........d5704e94708cbb7c319d471536942f02 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 25419617 08690189 |
|---|